en

PRODUCT DETAIL

TRISENOX 2 mg/ml infúzny koncentrát

Code 1863D
MA number EU/1/02/204/002
Product Form: con inf 10x6 ml/12 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX27 Arsenic trioxide
Shelf life: 48
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 05.03.2002
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 13.03.2023
eu-flag.png sk-flag.png